Green Cross Holdings Corporation (KRX:005250)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,970
+140 (0.88%)
At close: Nov 4, 2025
0.88%
Market Cap725.07B
Revenue (ttm)2.27T
Net Income (ttm)117.43B
Shares Out45.40M
EPS (ttm)2,586.53
PE Ratio6.17
Forward PEn/a
Dividend500.00 (3.16%)
Ex-Dividend DateDec 27, 2024
Volume102,834
Average Volume81,935
Open15,710
Previous Close15,830
Day's Range15,610 - 16,280
52-Week Range12,000 - 18,050
Beta0.70
RSI51.91
Earnings DateNov 14, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 144
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.